Chinese researchers have developed and externally validated a prediction model combining PSA, tumor stage, biopsy grade, and ...

The Metastatic Prostate Cancer clinical trial analysis report delivers important insights into ongoing research of 80+ ...

Prostate cancer has a well-earned reputation for being one of the more trackable malignancies in medicine. Since the mid-1980s, a single blood test measuring prostate-specific antigen, or PSA, has ...

Men in England diagnosed with incurable advanced prostate cancer are more likely to survive for at least three years than ...

NUCLIDIUM AG, a clinical-stage radiopharmaceutical company, today announced that the first patient has been successfully imaged in a Phase 2 clinical trial evaluating the diagnostic accuracy and ...

As the standards of care for prostate cancer change, new drugs, combination therapies, and trials enter the therapeutic space ...

When prostate cancer spreads beyond the prostate gland to other parts of the body, it becomes what medical professionals call metastatic prostate cancer. This advanced form of the disease represents a ...

Learn about common side effects of radioligand therapy for metastatic prostate cancer and effective strategies to manage them for better outcomes.

"The number of men living with prostate cancer also continues to rise, so it's vital that we see investment in prostate ...

Moving Beyond Imaging in metastatic castration-resistant prostate cancer: Liquid biopsy cfNA profiling of PTEN-FANCD2-POLQ as molecular signatures of response to 177Lu-PSMA-617. This is an ASCO ...

For men with genitourinary malignancies, such as prostate cancer, examining the external genital area is essential. While this may seem routine, it remains a crucial recommendation, as illustrated by ...

VIR-5500 and [²¹²Pb]PSV359 received FDA fast track designations for prostate cancer and solitary fibrous tumors, respectively ...